In this study, we reveal a previously unknown non-oncogene addiction to the PML gene in ccRCC by finding that PML is overexpressed in this tumor and that its genetic or pharmacologic inhibition triggers tumor-suppressive responses of cellular senescence and p53 induction. The gene discussed is PML; the disease is nonpapillary renal cell carcinoma.